Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 320 | 0 | 22 | 950 | 0 |
| Operating Expenses | 30,128 | 26,103 | 19,470 | 15,640 | 14,473 |
| Operating Income | -29,808 | -26,103 | -19,448 | -14,690 | -14,473 |
| Interest Expense | 43 | N/A | 20 | N/A | N/A |
| Other Income | -135 | 57 | 14,367 | 1,905 | 504 |
| Pre-tax Income | -29,986 | -26,046 | -5,102 | -12,785 | -13,969 |
| Income Tax | -4,311 | -2,684 | -2,915 | -2,371 | -4,125 |
| Net Income Continuous | -25,675 | -23,362 | -2,187 | -10,413 | -9,845 |
| Net Income | $-25,675 | $-23,362 | $-2,187 | $-10,413 | $-9,845 |
| EPS Basic Total Ops | -0.26 | -0.26 | -0.02 | -0.12 | -0.10 |
| EPS Basic Continuous Ops | -0.26 | -0.26 | -0.02 | -0.12 | -0.10 |
| EPS Diluted Total Ops | -0.26 | -0.26 | -0.02 | -0.12 | -0.10 |
| EPS Diluted Continuous Ops | -0.26 | -0.26 | -0.02 | -0.12 | -0.10 |
| EBITDA(a) | $-29,311 | $-25,596 | $-4,496 | $-14,307 | $-14,203 |